Clinical Trial: Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA(R)) of Depression and Anxiety Severity

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06923995) titled 'Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA(R)) of Depression and Anxiety Severity' on March 24.

Brief Summary: The SEQUOIA-1 study evaluates the effectiveness of Artificial Intelligence (AI) in measuring depression and anxiety severity in adults. Investigators from Deliberate Solutions, Inc. and Baylor College of Medicine are conducting this study to determine whether AI can provide reliable clinical assessments of mood and anxiety disorders.

In clinical trials for new depression and anxiety treatments, human clinicians typically conduct interviews to evaluate participants' symptoms. These assessments are...